BPMC logo

Blueprint Medicines (BPMC) Long Term Debt

Annual Long Term Debt

$411.84 M
+$121.56 M+41.87%

December 31, 2024


Summary


Performance

BPMC Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCbalance sheetmetrics:

Quarterly Long Term Debt

$411.84 M
-$1.61 M-0.39%

December 31, 2024


Summary


Performance

BPMC Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

BPMC Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+41.9%-0.5%
3 y3 years+298.6%-0.5%
5 y5 years+362.1%-0.5%

BPMC Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+298.6%-0.5%+319.6%
5 y5-yearat high+404.3%-0.5%+448.7%
alltimeall timeat high>+9999.0%-0.5%>+9999.0%

Blueprint Medicines Long Term Debt History

DateAnnualQuarterly
Dec 2024
$411.84 M(+41.9%)
$411.84 M(-0.4%)
Sep 2024
-
$413.45 M(-0.1%)
Jun 2024
-
$413.90 M(+43.9%)
Mar 2024
-
$287.69 M(-0.9%)
Dec 2023
$290.29 M(+35.0%)
$290.29 M(-0.7%)
Sep 2023
-
$292.19 M(+39.7%)
Jun 2023
-
$209.19 M(-1.4%)
Mar 2023
-
$212.07 M(-1.4%)
Dec 2022
$215.02 M(+108.1%)
$215.02 M(-1.6%)
Sep 2022
-
$218.56 M(+122.7%)
Jun 2022
-
$98.16 M(-2.6%)
Mar 2022
-
$100.76 M(-2.5%)
Dec 2021
$103.31 M(+26.5%)
$103.31 M(+37.7%)
Sep 2021
-
$75.05 M(-2.9%)
Jun 2021
-
$77.27 M(-2.8%)
Mar 2021
-
$79.48 M(-2.7%)
Dec 2020
$81.67 M(-8.4%)
$81.67 M(-2.5%)
Sep 2020
-
$83.73 M(-2.3%)
Jun 2020
-
$85.73 M(-2.2%)
Mar 2020
-
$87.67 M(-1.6%)
Dec 2019
$89.13 M
$89.13 M(-2.0%)
DateAnnualQuarterly
Sep 2019
-
$90.92 M(-1.9%)
Jun 2019
-
$92.65 M(-1.8%)
Mar 2019
-
$94.32 M(+631.0%)
Dec 2018
$12.90 M(-11.7%)
$12.90 M(-3.2%)
Sep 2018
-
$13.33 M(-3.1%)
Jun 2018
-
$13.76 M(-3.0%)
Mar 2018
-
$14.19 M(-2.9%)
Dec 2017
$14.62 M(+239.1%)
$14.62 M(+72.7%)
Sep 2017
-
$8.46 M(+128.9%)
Jun 2017
-
$3.70 M(-1.5%)
Mar 2017
-
$3.75 M(-12.9%)
Dec 2016
$4.31 M(-42.1%)
$4.31 M(-14.3%)
Sep 2016
-
$5.03 M(-12.5%)
Jun 2016
-
$5.75 M(-11.1%)
Mar 2016
-
$6.47 M(-13.0%)
Dec 2015
$7.44 M(+1.4%)
$7.44 M(-11.5%)
Sep 2015
-
$8.41 M(-10.3%)
Jun 2015
-
$9.37 M(+43.6%)
Mar 2015
-
$6.53 M(-11.1%)
Dec 2014
$7.34 M(+240.5%)
$7.34 M
Dec 2013
$2.15 M
-

FAQ

  • What is Blueprint Medicines annual long term debt?
  • What is the all time high annual long term debt for Blueprint Medicines?
  • What is Blueprint Medicines annual long term debt year-on-year change?
  • What is Blueprint Medicines quarterly long term debt?
  • What is the all time high quarterly long term debt for Blueprint Medicines?
  • What is Blueprint Medicines quarterly long term debt year-on-year change?

What is Blueprint Medicines annual long term debt?

The current annual long term debt of BPMC is $411.84 M

What is the all time high annual long term debt for Blueprint Medicines?

Blueprint Medicines all-time high annual long term debt is $411.84 M

What is Blueprint Medicines annual long term debt year-on-year change?

Over the past year, BPMC annual long term debt has changed by +$121.56 M (+41.87%)

What is Blueprint Medicines quarterly long term debt?

The current quarterly long term debt of BPMC is $411.84 M

What is the all time high quarterly long term debt for Blueprint Medicines?

Blueprint Medicines all-time high quarterly long term debt is $413.90 M

What is Blueprint Medicines quarterly long term debt year-on-year change?

Over the past year, BPMC quarterly long term debt has changed by -$2.06 M (-0.50%)